<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01439529</url>
  </required_header>
  <id_info>
    <org_study_id>BEST</org_study_id>
    <nct_id>NCT01439529</nct_id>
  </id_info>
  <brief_title>ECG Optimization of CRT: Evaluation of Mid-term Response</brief_title>
  <acronym>BEST</acronym>
  <official_title>Optimization of Response to Cardiac Resynchronization Therapy by Electrocardiogram: an Assessment of Medium-term Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      New simpler methods to optimize cardiac resynchronization therapy (CRT) are being evaluated,
      such as the use of the electrocardiogram.

      In this prospective, double-blind, study, the investigators will evaluate:

      Primary endpoint: To compare the clinical response to CRT in patients with the programming
      optimized by QRS versus the nominal suggested by the device.

      Secondary endpoints:

        1. To compare cardiac remodeling in patients with the programming optimized by QRS versus
           the nominal suggested by the device.

        2. To evaluate the degree of asynchrony in both groups (nominal versus optimization by QRS)
           with respect to the intrinsic rhythm.

        3. To evaluate the echocardiographic improvement in left ventricular (LV) filling in both
           groups.

        4. To evaluate the differences in the optimal atrioventricular (AV) delay with atrial
           sensing or atrial pacing.

      For that, 180 patients with an indication for CRT will be randomized to nominal programming
      of the device or optimization by the electrocardiogram for a narrower QRS. A clinical and
      echocardiographic evaluation will be done at baseline, 6 and 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical response</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical response: survival without heart transplantation or death and &gt;10% increased distance in the 6MWT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic response</measure>
    <time_frame>12 months</time_frame>
    <description>Echocardiographic response: &gt;15% decrease in LV end-systolic volume and survival without heart transplantation or death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pacing/sensing AV delay difference</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Nominal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CRT device is programmed with the nominal values.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Narrow QRS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CRT device is programmed by QRS optimization</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Device programming: nominal</intervention_name>
    <description>CRT device is programmed to nominal values</description>
    <arm_group_label>Nominal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Programming optimization by QRS</intervention_name>
    <description>CRT device is programmed by QRS optimization</description>
    <arm_group_label>Narrow QRS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: patients with standard indication of cardiac resynchronization

          -  Ejection fraction ≤35%.

          -  QRS duration ≥120 ms.

          -  New York Heart Association Functional Class 2-4..

          -  Left ventricular diameter ≥55 mm.

          -  Optimal medical treatment.

        Exclusion Criteria:

          -  Patient refusal.

          -  Cardiopathy with a reversible cause.

          -  Prevision of heart transplantation.

          -  Atrial fibrillation.

          -  Complete AV block.

          -  AV delay &gt;250 ms.

          -  Right bundle branch block.

          -  Severe peripheral vascular disease.

          -  Other diseases with &lt; 1 year life expectancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Arbelo, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Clinic Universitari de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lluís Mont, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Clínic Universitari de Barcelona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2011</study_first_submitted>
  <study_first_submitted_qc>September 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2011</study_first_posted>
  <last_update_submitted>August 9, 2017</last_update_submitted>
  <last_update_submitted_qc>August 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Elena Arbelo</investigator_full_name>
    <investigator_title>Coordinator of the AF programme</investigator_title>
  </responsible_party>
  <keyword>Cardiac</keyword>
  <keyword>Resynchronization</keyword>
  <keyword>Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

